Skip to content

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference

June 16, 2026

view ALL Events

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

All Rights Reserved.

About Us
Management
Board of Directors
Scientific Advisory Board
Careers
Contact Us

About LB-102
Pipeline
About Schizophrenia
Publications

Investors Overview
News
Events
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
Investor FAQs

© 2026 LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Scroll to Top